Medicine is entering a new era of breakthrough science, with innovations once considered out of reach now becoming reality. In neurology, researchers continue pursuing new approaches for devastating diseases like Alzheimer’s and Parkinson’s. The goal is simple: ensure companies and researchers continue investing in the next generation of lifesaving science. America has long led the world in medical innovation because it has supported bold research, rewarded innovation and encouraged investment in groundbreaking discoveries. But policymakers, insurers and healthcare leaders must also recognize that access matters just as much as innovation itself.